Id |
Subject |
Object |
Predicate |
Lexical cue |
T133 |
0-19 |
Sentence |
denotes |
Chemerin receptor 1 |
T134 |
20-211 |
Sentence |
denotes |
Chemerin receptor 1 (chemerin1, ChemR23, or ERV1) is expressed on a wide range of immune cells, including monocytes, macrophages, natural killer cells, bone marrow cells, and dendritic cells. |
T135 |
212-298 |
Sentence |
denotes |
Besides, ERV1 has been identified in adipocytes and endothelial cells (Luangsay et al. |
T136 |
299-305 |
Sentence |
denotes |
2009). |
T137 |
306-412 |
Sentence |
denotes |
ERV1 was initially classified as an orphan GPCR with homology to the formyl peptide receptor (Gantz et al. |
T138 |
413-477 |
Sentence |
denotes |
1996) and the anaphylatoxin C3a and C5a receptors (Samson et al. |
T139 |
478-589 |
Sentence |
denotes |
1998) until recently when it was discovered to be a receptor for the chemotactic protein chemerin (Meder et al. |
T140 |
590-596 |
Sentence |
denotes |
2003). |
T141 |
597-737 |
Sentence |
denotes |
In addition to chemerin, RvE1 was identified as a second endogenous agonist through a screening program against the GPCR panel (Arita et al. |
T142 |
738-744 |
Sentence |
denotes |
2007). |
T143 |
745-913 |
Sentence |
denotes |
ERV1 (chemokine like receptor 1, also known as CMKLR1) is a receptor for RvE1, which has been shown to bind more strongly than chemerin (a peptide ligand) (Arita et al. |
T144 |
914-935 |
Sentence |
denotes |
2005; Wittamer et al. |
T145 |
936-942 |
Sentence |
denotes |
2004). |
T146 |
943-1098 |
Sentence |
denotes |
ERV1 overexpressing mice showed a large increase in phagocytosis upon decreased neutrophil inhibition and decreased neutrophil infiltration (Herrera et al. |
T147 |
1099-1105 |
Sentence |
denotes |
2015). |
T148 |
1106-1208 |
Sentence |
denotes |
Also, RvE2 is a partial agonist compared to RvE1 in CHO-chemerin1 β-arrestin recruitment (Isobe et al. |
T149 |
1209-1216 |
Sentence |
denotes |
2012a). |
T150 |
1217-1352 |
Sentence |
denotes |
However, since there is no additional information on this ligand, further investigation of potential ligand-receptor pairs is required. |